Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
Irem Ozkan‐Dagliyan(University of North Carolina at Chapel Hill), Channing J. Der(University of North Carolina at Chapel Hill), Adrienne D. Cox(University of North Carolina at Chapel Hill), Bjoern Papke(University of North Carolina at Chapel Hill), Nhan L. Tran(Translational Genomics Research Institute), Samuel D. George(University of North Carolina at Chapel Hill), Emanuel F. Petricoin(Center for Biologics Evaluation and Research), Onur Dağliyan(Harvard University), Andrew M. Waters(University of North Carolina at Chapel Hill), Antje Schaefer(University of North Carolina at Chapel Hill), Thomas S.K. Gilbert(University of North Carolina at Chapel Hill), Kris C. Wood(Duke University), Laura E. Herring(University of North Carolina at Chapel Hill), Craig M. Goodwin(University of North Carolina at Chapel Hill), Krister Wennerberg(University of Copenhagen), Kathleen Klotz‐Noack(Charité - Universitätsmedizin Berlin), Mariaelena Pierobon(George Mason University), Kevin Lin(The University of Texas MD Anderson Cancer Center), J. Nathaniel Diehl(University of North Carolina at Chapel Hill), Lee M. Graves(University of North Carolina at Chapel Hill), Prson Gautam(University of Helsinki), Sen Peng(Translational Genomics Research Institute), Ramón V. Tiu(Eli Lilly (United States)), Christine Sers(Charité - Universitätsmedizin Berlin), Sheng-Bin Peng(Translational Genomics Research Institute), Shripad V. Bhagwat(Eli Lilly (United States))
Cited by 108
Related Papers
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Rho-family GTPases: it's not only Rac and Rho (and I like it)
|Journal of Cell Science|2004|594